UPSTREAM BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$3.41
+4.28%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-32.3%
3 months
-46.9%
6 months
-63.7%
1 year
-86.8%
Year to date
-87.4%
52-week range
$2.74 – $32.60
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$186.8M
P/E
-1.2
P/B
0.7
P/S
59.2
Revenue
$3.16M
Net income
-$156.5M
Diluted EPS
-2.89
Gross margin
100.00%
Net margin
-4955.70%
Return on equity
-48.40%
Total debt
$954K
Cash
$79.59M
Free cash flow
-$136.46M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $773K | -$39.7M | 100.00% | -5136.10% | -$35.62M |
| Mar 31, 2026 | $1.03M | -$40.59M | 100.00% | -3925.60% | -$47.85M |
| Dec 31, 2025 | $668K | -$42.46M | 100.00% | -6356.10% | -$30.69M |
| Sep 30, 2025 | $683K | -$33.75M | 100.00% | -4941.10% | -$22.3M |
| Jun 30, 2025 | $937K | -$39.97M | 100.00% | -4265.30% | -$39.29M |
| Mar 31, 2025 | $566K | -$27.27M | 100.00% | -4818.00% | -$41.17M |
| Dec 31, 2024 | $613K | -$21.24M | 100.00% | -3554.60% | -$19.8M |
| Sep 30, 2024 | $607K | -$15.99M | 100.00% | -3465.10% | -$14.29M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent UPB news
All market newsNo ticker-linked stories are in the current archive.